Small doses of arginine vasopressin in combination with norepinephrine "buy" time for definitive treatment for uncontrolled hemorrhagic shock in rats

Shock

Volumn 40, Issue 5, 2013, Pages 398-406

  Liu, Liangming ^a   Tian, Kunlun ^a   Xue, Mingying ^a   Zhu, Yu ^a   Lan, Dan ^a   Peng, Xiaoyong ^a   Wu, Yue ^a   Li, Tao ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

AVP; blood flow; fluid resuscitation; NE; Uncontrolled hemorrhagic shock

Indexed keywords

ARGIPRESSIN; NORADRENALIN; RINGER LACTATE SOLUTION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD VOLUME; CONTROLLED STUDY; EARLY INTERVENTION; FLUID RESUSCITATION; HEART FUNCTION; HEART OUTPUT; HEMODYNAMICS; HEMORRHAGIC SHOCK; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGEN TRANSPORT; RAT; SURVIVAL TIME; TISSUE BLOOD FLOW; UNCONTROLLED HEMORRHAGIC SHOCK;

ANIMALS; ARGININE VASOPRESSIN; CARBON DIOXIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; FLUID THERAPY; HEMODYNAMICS; NOREPINEPHRINE; OXYGEN; PARTIAL PRESSURE; RATS; RATS, SPRAGUE-DAWLEY; SECONDARY PREVENTION; SHOCK, HEMORRHAGIC; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 84887088632     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000036     Document Type: Article

References (26)

1. Bellamy RF: The cause of death in conventional land warfare: implication for combat casualty care research. Mil Med 149:55-62, 1984.
2. Cherkas D: Traumatic hemorrhagic shock: advances in fluid management. Emerg Med Pract 13:1-19, 2011.
3. Schrier RW, Berl T, Anderson RJ: Osmotic and nonosmotic control of vaso-pressin. Am J Physiol 236:F321YF332, 1979.
4. Dewachter P, Emala CW: Pre-exposure to vasopressin potentiates the vaso-constrictive effect of epinephrine in rat aorta isolated during late anaphylaxis. Shock 33:655-661, 2010.
5. Huang HC, Wang SS, Chang CC, Lee FY, Lin HC, Hou MC, Teng TH, Chen YC, Lee SD: Evolution of portal-systemic collateral vasopressin response in endotoxemic portal hypertensive rats. Shock 32:503-508, 2009.
6. Maybauer MO, Traber DL, Maybauer DM: Catecholamines, vasopressin and markers of acute liver injury in septic shock. Shock 31:222-223, 2009.
7. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, Oz MC, Oliver JA: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 195:1122-1125, 1997.
8. Landry DW, Levin HR, Gallant EM, Seo S, D'Alessandro D, Oz MC, Oliver JA: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 25:1279-1282, 1997.
9. Jochberger S, Zitt M, Luckner G, Mayr VD, Wenzel V, Ulmer H, Morgenthaler NG, Hasibeder WR, Dunser MW: Postoperative vasopressin and copeptin levels in noncardiac surgery patients: a prospective controlled trial. Shock 132-138, 2009.
10. Stadlbauer KH, Wenzela V, Wagner-Bergera HG, Kirsmera AC, Konigsrainerb A, Voelckela WG, Raedlera C, Schmittingera CA, Lindnera KH, Klimac G: An observational study of vasopressin infusion during uncontrolled haemorrhagic shock in a porcine trauma model: effects on bowel function. Resuscitation 72: 145-148, 2007.
11. Li T, Fang YQ, Zhu Y, Fang XQ, Liao ZF, Chen F, Liu LM: A small dose of arginine vasopressin in combination with norepinephrine is a good early treatment for uncontrolled hemorrhagic shock after hemosatsis. J Surg Res 169: 76-84, 2011.
12. Li T, Zhu Y, Hu Y, Diao YF, Liao ZF, Li P, Liu LM: Ideal permissive hypotension to resuscitate uncontrolled hemorrhagic shock and the tolerance time in rats. Anesthesiology 114:111-119, 2011.
13. Li T, Zhu Y, Fang YQ, Liu LM: Determining the optimal mean arterial pressure for post-bleeding resuscitation in traumatized rats. Anesthesiology 116: 103-112, 2012.
14. Li T, Lin XL, Zhu Y, Li LJ, Liu LM: Short-term, mild hypothermia can increase the beneficial effect of permissive hypotension on uncontrolled hemor-rhagic shock in rats. Anesthesiology 116: 1288-1298, 2012.
15. 2 receptor in AVP restoring the hemorrhage-induced vascular hyporeactivity and calcium desensitization and its mechanisms. J Surg Res 161:312-320, 2010.
16. Yang GM, Li T, Xu J, Liu LM: PKC plays an important mediated effect in arginine vasopressin induced restoration of vascular responsiveness and calcium sensitization following hemorrhagic shock in rats. Eur J Pharmacol 628: 148-154, 2010.
17. Stadlbauer KH, Wagner-Berger HG, Raedler C: Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs. Anesthesiology 98:699-704, 2003.
18. Martikainen TJ, Tenhunen JJ, Uusaro A, Ruokonen E: The effects of vaso-pressin on systemic and splanchnic hemodynamics and metabolism in endo-toxin shock. Anesth Analg 97:1756-1763, 2003.
19. Ouattara A, Landi M, Le Manach Y: Comparative cardiac effects of terlipressin, vasopressin, and norepinephrine on an isolated perfused rabbit heart. Anesthesi-ology 102:85-92, 2005.
20. Ryckwaert F, Virsolvy A, Fort A: Terlipressin, a provasopressin drug exhibits direct vasoconstrictor properties: consequences on heart perfusion and performance. Crit Care Med 37:876-881, 2009.
21. Malay MB, Ashton JL, Dahl K, Savage EB, Burchell SA, Ashton RC, Sciacca RR, Oliver JA, Landry DW: Heterogeneity of the vasoconstrictor effect of va-sopressin in septic shock. Crit Care Med 32:1327-1331, 2004.
22. Garćia-Villalón AL, Garcia JL, Fernández N, Monge L, Go¶mez B, Diéguez G: Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. Br J Pharmacol 118:1848-1854, 1996.
23. Nakajima Y, Baudry N, Duranteau J, Vicaut E: Effects of vasopressin, nor-epinephrine, and L-arginine on intestinal microcirculation in endotoxemia. Crit Care Med 34:1752-1757, 2006.
24. Martin K, Borgel D, Lerolle N: Decreased ADAMTS-13 (a disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure. Crit Care Med 35:2375-2382, 2007.
25. Ono T, Mimuro J, Madoiwa S: Severe secondary deficiency of von Willebrand factorYcleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood 107:528-534, 2006.
26. Russell JA, Walley KR, Singer J: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 358:877-887, 2008.